Congress funds Lyme disease research the easy way: a stamp
H.R. 4981 — Stamp Out Lyme Disease Act · Filed by Josh Gottheimer (D-NJ) · 13 cosponsors · Introduced Aug 15, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill authorizes the U.S. Postal Service to issue a special 'semipostal' stamp dedicated to Lyme disease research. A semipostal stamp costs slightly more than a regular stamp; the extra revenue goes directly to the National Institute of Allergy and Infectious Diseases (NIAID) for Lyme disease and tick-borne illness research. The stamp must be available for at least 6 years, and the research funding it generates cannot be used to reduce NIAID's regular congressional appropriations.
Why we flagged it
The bill's sole function is to establish a voluntary, opt-in revenue stream for Lyme disease research via a commemorative postal stamp. It is a straightforward public-health funding tool with no hidden provisions or narrow beneficiaries.
What the text implies
- The bill's effectiveness depends entirely on voluntary consumer participation; if uptake is low, research funding may be minimal despite good intent.
- The 6-year minimum duration creates a long-term commitment to a single disease focus, which may crowd out other tick-borne illnesses (e.g., Rocky Mountain spotted fever, babesiosis) unless NIAID allocates proceeds broadly.
The full analysis lists 3 implications of this text.
Who it affects
This bill creates a voluntary, low-friction funding mechanism for a serious public-health problem (Lyme disease affects ~476,000 Americans annually and costs the healthcare system up to $1.3 billion per year). Citizens who choose to buy the stamp contribute to research without any cost to taxpayers or reduction in existing medical funding.